Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Beam Therapeutics (BEAM) Return on Assets (2020 - 2025)

Beam Therapeutics (BEAM) has disclosed Return on Assets for 6 consecutive years, with 0.24% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Assets rose 9.0% to 0.24% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.24%, a 9.0% increase, with the full-year FY2025 number at 0.06%, up 23.0% from a year prior.
  • Return on Assets was 0.24% for Q4 2025 at Beam Therapeutics, up from 0.31% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.09% in Q4 2023 to a low of 0.53% in Q1 2021.
  • A 5-year average of 0.25% and a median of 0.25% in 2023 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: surged 38bps in 2022, then fell -24bps in 2024.
  • Beam Therapeutics' Return on Assets stood at 0.27% in 2021, then grew by 10bps to 0.24% in 2022, then skyrocketed by 62bps to 0.09% in 2023, then plummeted by -260bps to 0.33% in 2024, then rose by 27bps to 0.24% in 2025.
  • Per Business Quant, the three most recent readings for BEAM's Return on Assets are 0.24% (Q4 2025), 0.31% (Q3 2025), and 0.28% (Q2 2025).